The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

All agenciesFDA (Food)FDA (Drugs)FDA (Devices)USDA FSISCPSCNHTSAEPA

Category

All categoriesFoodDrugMedical DeviceVehicleConsumer Product

Minimum severity

Any3+ (High and above)4+ (High and above)5+ (High and above)

Clear filters

451–475 of 5047

  • HighFDA (Drugs)·D-0235-2026·2025-12-24

    [pending] BACLOFEN (BACLOFEN)

    Pending LLM rewrite. Source: FDA_DRUG D-0235-2026.

    Product
    BACLOFEN — BACLOFEN (BACLOFEN)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0232-2026·2025-12-24

    [pending] MEPIVACAINE (MEPIVACAINE HYDROCHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0232-2026.

    Product
    MEPIVACAINE — MEPIVACAINE (MEPIVACAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0233-2026·2025-12-24

    [pending] CARBOCAINE (MEPIVACAINE HYDROCHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0233-2026.

    Product
    CARBOCAINE — CARBOCAINE (MEPIVACAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0230-2026·2025-12-24

    [pending] POLOCAINE (MEPIVACAINE HYDROCHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0230-2026.

    Product
    POLOCAINE — POLOCAINE (MEPIVACAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0231-2026·2025-12-24

    [pending] MEPIVACAINE (MEPIVACAINE HYDROCHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0231-2026.

    Product
    MEPIVACAINE — MEPIVACAINE (MEPIVACAINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0225-2026·2025-12-17

    [pending] CINACALCET (CINACALCET)

    Pending LLM rewrite. Source: FDA_DRUG D-0225-2026.

    Product
    CINACALCET — CINACALCET (CINACALCET)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0223-2026·2025-12-17

    [pending] MORPHINE SULFATE (MORPHINE SULFATE)

    Pending LLM rewrite. Source: FDA_DRUG D-0223-2026.

    Product
    MORPHINE SULFATE — MORPHINE SULFATE (MORPHINE SULFATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0226-2026·2025-12-17

    [pending] CINACALCET (CINACALCET)

    Pending LLM rewrite. Source: FDA_DRUG D-0226-2026.

    Product
    CINACALCET — CINACALCET (CINACALCET)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0221-2026·2025-12-17

    [pending] Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophthalmic Solution, 0.5m

    Pending LLM rewrite. Source: FDA_DRUG D-0221-2026.

    Product
    Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophthalmic Solution, 0.5mL Single-Use Syringe, For Topical Ophthalmic Use Only. Not for IV Use. Fagron Sterile Services, 8710 E 34th St N, Wichita, KS 67226. NDC: 71266-8240-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0217-2026·2025-12-17

    [pending] LANTHANUM CARBONATE (LANTHANUM CARBONATE)

    Pending LLM rewrite. Source: FDA_DRUG D-0217-2026.

    Product
    LANTHANUM CARBONATE — LANTHANUM CARBONATE (LANTHANUM CARBONATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0220-2026·2025-12-17

    [pending] GANIRELIX ACETATE (GANIRELIX ACETATE)

    Pending LLM rewrite. Source: FDA_DRUG D-0220-2026.

    Product
    GANIRELIX ACETATE — GANIRELIX ACETATE (GANIRELIX ACETATE)
    Category
    Drug
    Distribution
    4 states
  • HighFDA (Drugs)·D-0218-2026·2025-12-17

    [pending] LANTHANUM CARBONATE (LANTHANUM CARBONATE)

    Pending LLM rewrite. Source: FDA_DRUG D-0218-2026.

    Product
    LANTHANUM CARBONATE — LANTHANUM CARBONATE (LANTHANUM CARBONATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0219-2026·2025-12-17

    [pending] VARENICLINE TARTRATE (VARENICLINE TARTRATE)

    Pending LLM rewrite. Source: FDA_DRUG D-0219-2026.

    Product
    VARENICLINE TARTRATE — VARENICLINE TARTRATE (VARENICLINE TARTRATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0222-2026·2025-12-17

    [pending] NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0222-2026.

    Product
    NEBIVOLOL — NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0224-2026·2025-12-17

    [pending] CINACALCET (CINACALCET)

    Pending LLM rewrite. Source: FDA_DRUG D-0224-2026.

    Product
    CINACALCET — CINACALCET (CINACALCET)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0209-2026·2025-12-10

    [pending] NIVAGEN ZINC OXIDE (ZINC OXIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0209-2026.

    Product
    NIVAGEN ZINC OXIDE — NIVAGEN ZINC OXIDE (ZINC OXIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0206-2026·2025-12-10

    [pending] NIVAGEN ZINC OXIDE (ZINC OXIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0206-2026.

    Product
    NIVAGEN ZINC OXIDE — NIVAGEN ZINC OXIDE (ZINC OXIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0215-2026·2025-12-10

    [pending] DULOXETINE (DULOXETINE HYDROCHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0215-2026.

    Product
    DULOXETINE — DULOXETINE (DULOXETINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0216-2026·2025-12-10

    [pending] DULOXETINE (DULOXETINE HYDROCHLORIDE)

    Pending LLM rewrite. Source: FDA_DRUG D-0216-2026.

    Product
    DULOXETINE — DULOXETINE (DULOXETINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide